Ola Åberg

431 total citations
21 papers, 347 citations indexed

About

Ola Åberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Ola Åberg has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Ola Åberg's work include Peptidase Inhibition and Analysis (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ola Åberg is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ola Åberg collaborates with scholars based in Sweden, United Kingdom and Switzerland. Ola Åberg's co-authors include Bengt Långström, Eric O. Aboagye, Jonas Eriksson, Sebastian Trousil, Maciej Kaliszczak, Meg Perumal, Mats Larhed, Quang‐Dé Nguyen, Federica Pisaneschi and Elizabeth Stevens and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Ola Åberg

21 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Åberg Sweden 13 131 128 111 74 49 21 347
Mohammad B. Haskali Australia 12 106 0.8× 201 1.6× 104 0.9× 78 1.1× 86 1.8× 39 380
Magne Solbakken Norway 10 171 1.3× 263 2.1× 98 0.9× 103 1.4× 42 0.9× 14 428
Alexander Vanderbilt United States 11 117 0.9× 262 2.0× 161 1.5× 37 0.5× 11 0.2× 12 433
Minhao Huang China 10 197 1.5× 34 0.3× 82 0.7× 121 1.6× 13 0.3× 19 337
J. Bonafous France 8 172 1.3× 205 1.6× 123 1.1× 40 0.5× 13 0.3× 13 363
Ashour Mohammed Germany 11 157 1.2× 214 1.7× 95 0.9× 33 0.4× 13 0.3× 13 349
Jeroen Verhoeven Belgium 12 138 1.1× 116 0.9× 63 0.6× 81 1.1× 9 0.2× 30 317
Maciej Kaliszczak United Kingdom 14 274 2.1× 132 1.0× 153 1.4× 136 1.8× 7 0.1× 23 482
Louis Allott United Kingdom 11 89 0.7× 306 2.4× 145 1.3× 57 0.8× 33 0.7× 28 420
Toshiaki Tsunenari United States 15 189 1.4× 104 0.8× 175 1.6× 92 1.2× 7 0.1× 27 513

Countries citing papers authored by Ola Åberg

Since Specialization
Citations

This map shows the geographic impact of Ola Åberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Åberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Åberg more than expected).

Fields of papers citing papers by Ola Åberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Åberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Åberg. The network helps show where Ola Åberg may publish in the future.

Co-authorship network of co-authors of Ola Åberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Åberg. A scholar is included among the top collaborators of Ola Åberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Åberg. Ola Åberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samanta, Sumanta, Vadim Le Joncour, Vignesh Kumar Rangasami, et al.. (2022). Heparin‐Derived Theranostic Nanoprobes Overcome the Blood–Brain Barrier and Target Glioma in Murine Model. Advanced Therapeutics. 5(6). 11 indexed citations
2.
Persson, Jonas, Bo Zhang, Irina Velikyan, et al.. (2021). Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69. Scientific Reports. 11(1). 19151–19151. 17 indexed citations
3.
Rosestedt, Maria�, Irina Velikyan, Ulrika Rosenström, et al.. (2020). Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nuclear Medicine and Biology. 93. 54–62. 12 indexed citations
4.
Nordeman, Patrik, Emmanuelle Briard, Mats Larhed, et al.. (2020). 18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand. European Journal of Pharmaceutical Sciences. 157. 105647–105647. 2 indexed citations
5.
Hellström‐Lindahl, Ewa, Ola Åberg, Cecilia Ericsson, et al.. (2017). Toward molecular imaging of the free fatty acid receptor 1. Acta Diabetologica. 54(7). 663–668. 1 indexed citations
6.
Eriksson, Jonas, Ola Åberg, Ram Kumar Selvaraju, et al.. (2014). Strategy to develop a MAO-A-resistant 5-hydroxy-l-[β-11C]tryptophan isotopologue based on deuterium kinetic isotope effects. EJNMMI Research. 4(1). 62–62. 2 indexed citations
7.
Åberg, Ola, Zohreh Varasteh, Gunnar Lindeberg, et al.. (2013). (AlF)-F-18-labelling of NOTA-P2-RM26 and its evaluation as a PET ligand for GRPR/BB2. Journal of Labelled Compounds and Radiopharmaceuticals. 56. 1 indexed citations
8.
Varasteh, Zohreh, Ola Åberg, Gunnar Lindberg, et al.. (2013). GRPR antagonist NOTA-P2-RM26 labeled with fluorine-18 : radiochemistry, in vitro and in vivo evaluation. European Journal of Nuclear Medicine and Molecular Imaging. 40. 1 indexed citations
9.
Stevens, Elizabeth, Ola Åberg, Quang‐Dé Nguyen, et al.. (2013). Preclinical evaluation of a CXCR4-specific 68Ga-labelled TN14003 derivative for cancer PET imaging. Bioorganic & Medicinal Chemistry. 22(2). 796–803. 22 indexed citations
10.
Varasteh, Zohreh, Ola Åberg, Irina Velikyan, et al.. (2013). In Vitro and In Vivo Evaluation of a 18F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging. PLoS ONE. 8(12). e81932–e81932. 40 indexed citations
11.
Kaliszczak, Maciej, et al.. (2013). A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth. British Journal of Cancer. 108(2). 342–350. 53 indexed citations
12.
Trousil, Sebastian, Laurence Carroll, Andrew Kalusa, et al.. (2013). Design of symmetrical and nonsymmetrical N,N-dimethylaminopyridine derivatives as highly potent choline kinase alpha inhibitors. MedChemComm. 4(4). 693–693. 17 indexed citations
13.
Pisaneschi, Federica, Elizabeth Stevens, Quang‐Dé Nguyen, et al.. (2013). Scavenging strategy for specific activity improvement: application to a new CXCR4‐specific cyclopentapeptide positron emission tomography tracer. Journal of Labelled Compounds and Radiopharmaceuticals. 56(13). 679–685. 9 indexed citations
14.
Åberg, Ola & Bengt Långström. (2012). Combinatorial synthesis of labelled drugs and PET tracers: synthesis of a focused library of 11C‐carbonyl‐labelled acrylamides as potential biomarkers of EGFR expression. Journal of Labelled Compounds and Radiopharmaceuticals. 55(14). 477–483. 16 indexed citations
15.
Åberg, Ola, Federica Pisaneschi, Graham Smith, et al.. (2011). 18F-labelling of a cyclic pentapeptide inhibitor of the chemokine receptor CXCR4. Journal of Fluorine Chemistry. 135. 200–206. 13 indexed citations
16.
Åberg, Ola, Marc Y. Stevens, Jonas Lindh, et al.. (2010). Synthesis and evaluation of a 11C‐labelled angiotensin II AT2 receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals. 53(10). 616–624. 9 indexed citations
17.
Åberg, Ola & Bengt Långström. (2010). Synthesis of substituted [11C]ureas and [11C]sulphonylureas by Rh(I)‐mediated carbonylation. Journal of Labelled Compounds and Radiopharmaceuticals. 54(1). 38–42. 25 indexed citations
18.
Ilovich, Ohad, Ola Åberg, Bengt Långström, & Eyal Mishani. (2009). Rhodium‐mediated [11C]carbonylation: a library of N‐phenyl‐N′‐{4‐(4‐quinolyloxy)‐phenyl}‐[11C]‐urea derivatives as potential PET angiogenic probes. Journal of Labelled Compounds and Radiopharmaceuticals. 52(5). 151–157. 23 indexed citations
19.
Åberg, Ola, Örjan Lindhe, Håkan Hall, et al.. (2009). Synthesis and biological evaluation of [carboxyl‐11C]eprosartan. Journal of Labelled Compounds and Radiopharmaceuticals. 52(8). 295–303. 13 indexed citations
20.
Eriksson, Jonas, Ola Åberg, & Bengt Långström. (2006). Synthesis of [11C]/[13C]Acrylamides by Palladium‐Mediated Carbonylation. European Journal of Organic Chemistry. 2007(3). 455–461. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad B. Haskali Breakdown of academic impact, for papers by Magne Solbakken Breakdown of academic impact, for papers by Alexander Vanderbilt Breakdown of academic impact, for papers by Minhao Huang Breakdown of academic impact, for papers by J. Bonafous Breakdown of academic impact, for papers by Ashour Mohammed Breakdown of academic impact, for papers by Jeroen Verhoeven Breakdown of academic impact, for papers by Maciej Kaliszczak Breakdown of academic impact, for papers by Louis Allott Breakdown of academic impact, for papers by Toshiaki Tsunenari
Rankless by CCL
2026